维恩妥尤联合帕博利珠单抗一线治疗既往未接受治疗的晚期尿路上皮癌的成本-效用分析

利欣欣, 牟洪利, 李思陈, 王淑玲

Cost-effectiveness analysis of the combination of enfortumab vedotin and pembrolizumab in first-line treatment of previously untreated advanced urothelial carcinoma

LI Xin-xin, MOU Hong-li, LI Si-chen, WANG Shu-lin

中国新药杂志 . 2026, (17): 1898 -1904 . DOI: 10.20251/j.cnki.1003-3734.2026.17.014